Clinical Trial Update: A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase I pediatric trial evaluating the combination of the menin inhibitor ziftomenib with venetoclax and gemtuzumab ozogamicin in acute myeloid leukemia, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab ozogamicin (Mylotarg) (gemtuzumab ozogamicin)
• Venetoclax (venetoclax)
• Ziftomenib (ziftomenib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING